These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 30246010)
1. EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials. Klingmann I; Heckenberg A; Warner K; Haerry D; Hunter A; May M; See W Front Med (Lausanne); 2018; 5():251. PubMed ID: 30246010 [TBL] [Abstract][Full Text] [Related]
2. EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D. Warner K; See W; Haerry D; Klingmann I; Hunter A; May M Front Med (Lausanne); 2018; 5():270. PubMed ID: 30356834 [TBL] [Abstract][Full Text] [Related]
3. EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes. Haerry D; Landgraf C; Warner K; Hunter A; Klingmann I; May M; See W Front Med (Lausanne); 2018; 5():230. PubMed ID: 30175100 [TBL] [Abstract][Full Text] [Related]
4. EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment. Hunter A; Facey K; Thomas V; Haerry D; Warner K; Klingmann I; May M; See W Front Med (Lausanne); 2018; 5():231. PubMed ID: 30238004 [TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
6. The Role of EUPATI CH in Promoting Patient Involvement in Clinical Research: A Multi-Stakeholder Research Project. Sessa C; Schmid C; Tolotti A; Magnin A; Haerry D; Bonetti L; Klingmann I Front Med (Lausanne); 2021; 8():795659. PubMed ID: 35004770 [No Abstract] [Full Text] [Related]
7. The Launch of the European Patients' Academy on Therapeutic Innovation in the Netherlands: A Qualitative Multi-Stakeholder Analysis. van Rensen A; Voogdt-Pruis HR; Vroonland E Front Med (Lausanne); 2020; 7():558. PubMed ID: 33072776 [No Abstract] [Full Text] [Related]
8. Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol. Taljaard M; Weijer C; Grimshaw JM; Ali A; Brehaut JC; Campbell MK; Carroll K; Edwards S; Eldridge S; Forrest CB; Giraudeau B; Goldstein CE; Graham ID; Hemming K; Hey SP; Horn AR; Jairath V; Klassen TP; London AJ; Marlin S; Marshall JC; McIntyre L; McKenzie JE; Nicholls SG; Alison Paprica P; Zwarenstein M; Fergusson DA Trials; 2018 Sep; 19(1):525. PubMed ID: 30261933 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
11. Conflicts of interest in research involving human beings. Greco D; Diniz NM J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007 [TBL] [Abstract][Full Text] [Related]
12. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology policy statement: oversight of clinical research. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281 [TBL] [Abstract][Full Text] [Related]
14. Critical Care Network in the State of Qatar. Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of clinical trials by Ethics Committees in Germany: experience of applicants with the review of requests for opinion of the Ethics Committees - results of a survey among members of the German Association of Research-Based Pharmaceutical Companies (VFA). Russ H; Busta S; Riedel A; Zöllner G; Jost B Ger Med Sci; 2009 Jul; 7():Doc07. PubMed ID: 19675747 [TBL] [Abstract][Full Text] [Related]
16. Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience. Martin JH; Hill C; Walsh A; Efron D; Taylor K; Kennedy M; Galettis R; Lightfoot P; Hanson J; Irving H; Agar M; Lacey J Trials; 2020 Nov; 21(1):932. PubMed ID: 33203469 [TBL] [Abstract][Full Text] [Related]
17. Informing a European guidance framework on electronic informed consent in clinical research: a qualitative study. De Sutter E; Borry P; Huys I; Barbier L BMC Health Serv Res; 2023 Feb; 23(1):181. PubMed ID: 36810088 [TBL] [Abstract][Full Text] [Related]
18. Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients? Atzor S; Gokhale S; Doherty M Pharmaceut Med; 2013 Apr; 27(2):75-82. PubMed ID: 23585715 [TBL] [Abstract][Full Text] [Related]